Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Aug 26, 2024; 12(24): 5492-5501
Published online Aug 26, 2024. doi: 10.12998/wjcc.v12.i24.5492
Table 4 Association between the protein profile of TEX14 and clinical pathology
Pathological features

n
TEX14
χ2 value
P value
Positive, n = 61
Negative,
n = 25
Age≥ 65 years 5436 (66.67)18 (33.33)1.2790.258
< 65 years 3225 (78.13)7 (21.88)
SexMale4735 (74.47)12 (25.53)0.6290.428
Female3926 (66.67)13 (33.33)
Pathological typeTubular adenocarcinoma3323 (69.70)10 (30.30)0.7150.699
Villous adenocarcinoma2718 (66.67)9 (33.33)
Papillary carcinoma2620 (76.92)6 (23.08)
Tumor diameter≥ 3 cm4630 (65.22)16 (34.78)1.5650.211
< 3 cm4031 (77.50)9 (22.50)
Differentiation degreeLow differentiation2715 (55.56)12 (44.44)6.6020.037
Moderate differentiation2517 (68.00)8 (32.00)
High differentiation3429 (85.29)5 (14.71)
TNM stagingStages I-II3721 (56.76)16 (43.24)6.3270.012
Stages III-IV4940 (81.63)9 (18.37)
Lymph node metastasisPresence5343 (83.13)10 (18.87)6.9720.008
Absence3318 (54.55)15 (45.45)
Infiltration depthT1 + T23721 (56.76)16 (43.24)6.4860.039
T34133 (80.49)8 (19.51)
T487 (87.50)1 (12.5)
Distant metastasisPresence4637 (80.43)9 (19.57)4.3330.037
Absence4024 (60.00)16 (40.00)